Missed GME or NVDA? Don’t Miss the Next One.​
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
Home › Stocks › MTBC Inc (MTBC) Stock Forecast & Price Prediction United States | NASDAQ | |
$2.12
+0.05 (2.42%)10 Quality Stocks Worth Considering Now
Researching MTBC (MTBC) after the drop? Our ex-Goldman Sachs analyst reveals if it made our list of 10 oversold quality stocks with strong growth potential.
Get our FREE market selloff report + exclusive analysis on MTBC and similar high-potential opportunities.
MTBC has shown a year-to-date change of -44.4% and a 1-year change of -16.5%, reflecting downward momentum over the past year. Comprehensive analyst forecasts are currently unavailable for MTBC. Please refer to the price chart above for recent performance and trends.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
These are the latest 20 analyst ratings and price targets for MTBC.
Date | Firm | Analyst | Rating | Change | Price Target |
---|---|---|---|---|---|
Dec 13, 2022 | Maxim Group | Allen Klee | Buy | Maintains | $12.00 |
Mar 15, 2022 | B. Riley Securities | Marc Wiesenberger | Buy | Maintains | $11.00 |
Jun 11, 2021 | Cantor Fitzgerald | Overweight | Initiates | $0.00 | |
Nov 25, 2020 | Summer Street | Buy | Initiates | $0.00 | |
Nov 25, 2020 | B. Riley | Buy | Initiates | $0.00 | |
Nov 25, 2020 | B. Riley FBR | Buy | Maintains | $0.00 | |
Nov 25, 2020 | HC Wainwright & Co. | Buy | Maintains | $0.00 | |
Nov 25, 2020 | Ladenburg Thalmann | Buy | Initiates | $0.00 | |
Nov 25, 2020 | National Securities | Buy | Initiates | $0.00 | |
Nov 25, 2020 | Benchmark | Buy | Initiates | $0.00 | |
Nov 25, 2020 | Chardan Capital | Buy | Maintains | $0.00 | |
Nov 25, 2020 | H.C. Wainwright | Neutral | Downgrade | $0.00 | |
Aug 18, 2020 | HC Wainwright & Co. | Buy | Maintains | $14.00 | |
May 15, 2020 | B. Riley Securities | Buy | Maintains | $8.50 | |
Nov 14, 2017 | Chardan Capital | Keay Nakae | Buy | Maintains | $2.75 |
Feb 23, 2015 | Chardan Capital | Buy | Assumes | $6.25 |
The following stocks are similar to MTBC based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
MTBC Inc has a market capitalization of $32.03M with a P/E ratio of -3.2x. The company generates $138.83M in trailing twelve-month revenue with a 39.2% profit margin.
Revenue growth is -3.5% quarter-over-quarter, while maintaining an operating margin of +4.3% and return on equity of +35.2%.
Get All 10 Quality Stocks For This Market Selloff
Still researching investments after the market drop? Our ex-Goldman Sachs analyst has already identified the 10 highest-quality oversold stocks with strong fundamentals and upside potential.
Why spend hours researching when we've already done the work? Get instant access to our complete market selloff analysis.
CareCloud, Inc. reports rising demand for its digital health solution, CareCloud Wellness, expected to accelerate throughout 2023.
Rising demand for CareCloud Wellness indicates potential revenue growth, enhancing CareCloud's market position and attractiveness to investors as digital health solutions gain traction.
CareCloud, Inc. will host investor meetings on Jan. 10-11, 2023, during the J.P. Morgan Healthcare Conference in San Francisco, featuring CEO A. Hadi Chaudhry and CFO Bill Korn.
CareCloud's leadership meeting at a prominent healthcare conference signals potential strategic developments, influencing investor sentiment and stock performance in the healthcare tech sector.
CareCloud, Inc. announced that Alpine Ear Nose and Throat PC will use its Meridian division's revenue cycle management solution to enhance administrative operations and cash flow.
CareCloud's new partnership with Alpine Ear Nose and Throat PC highlights its growth in revenue cycle management, potentially boosting its market position and financial performance.
CareCloud, Inc. (Nasdaq: MTBC, MTBCO, MTBCP) is sponsoring the APPNA 2022 winter meeting from Dec. 22-25 at Nishtar Medical University in Pakistan.
CareCloud's sponsorship of a major medical conference enhances its brand visibility, strengthens industry networks, and may lead to strategic partnerships, positively impacting future growth and stock performance.
CareCloud, Inc. announced that its medSR division's IT strategy contributed to King's Daughters Medical Center CIO Carl Smith receiving the 2022 Info-Tech CIO Award.
Recognition of CareCloud's IT strategy enhances its reputation in healthcare tech, potentially attracting new clients and boosting revenue, positively influencing stock performance.
CareCloud will change its Nasdaq symbol from MTBC to CCLD, highlighting its strengths and opportunities in a recent leadership presentation.
The Nasdaq symbol change to CCLD may enhance CareCloud's visibility and attract new investors, signaling a potential shift in market perception and growth opportunities.
Analyst forecasts for MTBC Inc (MTBC) are not currently available. The stock is trading at $2.12.
According to current analyst ratings, MTBC has 1 Buy ratings, 0 Hold ratings, and 0 Sell ratings. The stock is currently trading at $2.12. Always conduct your own research and consider your investment goals before making investment decisions.
Price predictions from Wall Street analysts for MTBC are not currently available. The stock is trading at $2.12.
N/A
Price targets from Wall Street analysts for MTBC are not currently available. The stock is trading at $2.12.
Price targets from Wall Street analysts for MTBC are not currently available. The stock is trading at $2.12.
The overall analyst consensus for MTBC is bullish. Out of 4 Wall Street analysts, 1 rate it as Buy, 0 as Hold, and 0 as Sell.
Stock price projections, including those for MTBC Inc, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.